Benchmark Glycan Profile of Therapeutic Monoclonal Antibodies Produced by Mammalian Cell Expression Systems
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- Extent
-
1 Online-Ressource.
- Language
-
Englisch
- Bibliographic citation
-
Benchmark Glycan Profile of Therapeutic Monoclonal Antibodies Produced by Mammalian Cell Expression Systems ; day:1 ; month:11 ; year:2023 ; pages:1-9
Pharmaceutical research ; (1.11.2023), 1-9
- Creator
-
Luo, Shen
Zhang, Baolin
- Contributor
-
SpringerLink (Online service)
- DOI
-
10.1007/s11095-023-03628-4
- URN
-
urn:nbn:de:101:1-2024011821041266394532
- Rights
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
15.08.2025, 7:30 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Luo, Shen
- Zhang, Baolin
- SpringerLink (Online service)
Other Objects (12)
Cell-based glycan arrays for probing glycan–glycan binding protein interactions
Proteomic identification of mammalian cell surface derived glycosylphosphatidylinositol‐anchored proteins through selective glycan enrichment
Protein aggregation during bioprocessing of monoclonal antibodies in mammalian cell culture
Highly sensitive characterization of non-human glycan structures of monoclonal antibody drugs utilizing tandem mass spectrometry
Automated Glycan Assembly of 19 F‐labeled Glycan Probes Enables High‐Throughput NMR Studies of Protein–Glycan Interactions
O-glycan profiling of serum glycan for potential renal cancer biomarkers
Large naturally-produced electric currents and voltage traverse damaged mammalian spinal cord
Glyco-engineering towards sialylation of recombinant human proteins and glycan analysis of synthetic complement regulators produced in Physcomitrella
Synthesis of a glycan hairpin
Optimizing effector functions of monoclonal antibodies via tailored N-glycan engineering using a dual landing pad CHO targeted integration platform
Direct glycosylation analysis of intact monoclonal antibodies combining ESI MS of glycoforms and MALDI-in source decay MS of glycan fragments
Technology transfer and scale down model development strategy for biotherapeutics produced in mammalian cells
Cell-based glycan arrays for probing glycan–glycan binding protein interactions
Proteomic identification of mammalian cell surface derived glycosylphosphatidylinositol‐anchored proteins through selective glycan enrichment
Protein aggregation during bioprocessing of monoclonal antibodies in mammalian cell culture
Highly sensitive characterization of non-human glycan structures of monoclonal antibody drugs utilizing tandem mass spectrometry
Automated Glycan Assembly of 19 F‐labeled Glycan Probes Enables High‐Throughput NMR Studies of Protein–Glycan Interactions
O-glycan profiling of serum glycan for potential renal cancer biomarkers
Large naturally-produced electric currents and voltage traverse damaged mammalian spinal cord
Glyco-engineering towards sialylation of recombinant human proteins and glycan analysis of synthetic complement regulators produced in Physcomitrella
Synthesis of a glycan hairpin
Optimizing effector functions of monoclonal antibodies via tailored N-glycan engineering using a dual landing pad CHO targeted integration platform
Direct glycosylation analysis of intact monoclonal antibodies combining ESI MS of glycoforms and MALDI-in source decay MS of glycan fragments
Technology transfer and scale down model development strategy for biotherapeutics produced in mammalian cells
Cell-based glycan arrays for probing glycan–glycan binding protein interactions
Proteomic identification of mammalian cell surface derived glycosylphosphatidylinositol‐anchored proteins through selective glycan enrichment
Protein aggregation during bioprocessing of monoclonal antibodies in mammalian cell culture
Highly sensitive characterization of non-human glycan structures of monoclonal antibody drugs utilizing tandem mass spectrometry
Automated Glycan Assembly of 19 F‐labeled Glycan Probes Enables High‐Throughput NMR Studies of Protein–Glycan Interactions
O-glycan profiling of serum glycan for potential renal cancer biomarkers
Large naturally-produced electric currents and voltage traverse damaged mammalian spinal cord
Glyco-engineering towards sialylation of recombinant human proteins and glycan analysis of synthetic complement regulators produced in Physcomitrella
Synthesis of a glycan hairpin
Optimizing effector functions of monoclonal antibodies via tailored N-glycan engineering using a dual landing pad CHO targeted integration platform
Direct glycosylation analysis of intact monoclonal antibodies combining ESI MS of glycoforms and MALDI-in source decay MS of glycan fragments